The Daily Brief

India's food inflation rises to 7.7% amid weak monsoon and El Niño, pressuring rural economy

32 min Listen to the original Episode page
India InflationMonsoonEl NiñoAgriculturePharmaceuticalsCommoditiesRBIFertilizer Subsidies

Summary

The speaker reports that India's retail food inflation jumped to 7.7% in September 2026, driven by sharp increases in vegetable, pulse, and cooking oil prices, despite headline inflation remaining within the RBI's target band. This rise is attributed to a weak monsoon, El Niño effects, and soaring global energy and fertilizer costs, which threaten both summer and winter crop yields. The episode highlights that rural inflation crossed 6% for the first time in the financial year, while national combined inflation stood at 5.5%. In the pharma sector, strong sales growth is offset by declining profits due to acquisition costs, pre-launch spending, and regulatory pressures. The segment concludes with updates on a 62,370 crore rupee fertilizer subsidy, RBI transfer rules, and Adani Group investments.

Key takeaways

  1. 1
    jumped to 7.7% up from 6% in August. In rural India, overall inflation crossed 6% for the first time this financial year. Now, India hasn't breached the RBIs of official inflation band of 2% to 6%. That's because the band applies to national combined inflation, which stood at 5.5%

    Sahidi · 1:03

  2. 2
    prices jumped nearly 36% in September alone. Wholesale onion prices, meanwhile, have nearly tripled. They were still 8.6% cheaper than a year earlier, but between April and September, tomatoes prices had actually risen 42%.

    Sahidi · 3:46

  3. 3
    According to official data from India and the US, 7 of India's 10 deficient summer monsoons between 1965 and 2025 happened during El Nino years.

    Sahidi · 9:12

  4. 4
    Global commodity prices rose significantly: Malaysian palm oil cost $1,120 per ton in October 2026 (up 14.3% from December 2025), and Thai broken rice reached $489 per ton (up more than 28% since March 2026).

    Sahidi · 10:12

Episode sections

  1. 0:57 – 16:11

    India's Food Inflation Gets Worrisome

    The speaker explains that India's retail food inflation jumped to 7.7% in September 2026, driven by rising prices of vegetables, pulses, and cooking oil, despite headline inflation remaining within the RBI's target band due to stable services and fuel prices. The rise is attributed to a weak monsoon, El Niño effects, and higher global energy and fertilizer costs, which threaten both summer and winter crop yields.

  2. 16:11 – 29:49

    The Profit Puzzle in Indian Pharma

    Despite strong sales growth in India's pharmaceutical sector, companies like Sun Pharma, Torrent Pharma, and Zydus Lifesciences face declining or pressured profits due to one-time acquisition costs, pre-launch spending for new drugs, and intense competition in generic markets. Regulatory changes in India and the US, including margin caps and tariffs, further complicate profitability outlooks.

  3. The segment covers quick updates including a 62,370 crore rupee fertilizer subsidy approval by the Union Cabinet, updated RBI rules for domestic money transfers, Adani Group's $1.45 billion equity investment for Evo Terminals, Paytm Finance's planned QIP, and foreign airlines' opposition to Adani's Mumbai Airport capacity reduction plan.

Claims worth verifying

India's retail food inflation jumped to 7.7% in September 2026, up from 6% in August.

Sahidi ·1:03

How to verify: Check India's Consumer Price Index (CPI) data released by the National Statistical Office (NSO) for September 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

National combined inflation stood at 5.5% in September 2026, within the RBI's 2% to 6% band.

Sahidi ·1:23

How to verify: Check India's CPI data released by the National Statistical Office (NSO) for September 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

Vegetable, tuber, and pulse prices rose 19% between April and August 2026 according to MOSP's retail price index.

Sahidi ·2:43

How to verify: Review Ministry of Statistics and Programme Implementation (MOSP) Retail Price Index data for vegetables, tubers, and pulses for April-August 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

Retail onion prices jumped nearly 36% in September 2026, and wholesale prices nearly tripled.

Sahidi ·3:46

How to verify: Check MOSP daily wholesale price reports and retail price surveys for onions in September 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

Tomato prices rose 42% between April and September 2026.

Sahidi ·4:06

How to verify: Check MOSP daily wholesale price reports for tomatoes for the period April-September 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

India's June-September 2026 monsoon rainfall was 13.5% below the 50-year average.

Sahidi ·6:56

How to verify: Check final monsoon rainfall reports from the India Meteorological Department (IMD) for the 2026 season. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

East and Northeast India received 74% of normal rainfall during the 2026 monsoon, the lowest since 1901.

Sahidi ·7:16

How to verify: Check IMD regional rainfall data for 2026 and historical rainfall records for East/Northeast India. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

US estimates in October 2026 put the probability of a strong El Niño continuing into Jan-March 2027 at more than 83%.

Sahidi ·9:52

How to verify: Check the NOAA (National Oceanic and Atmospheric Administration) Climate Prediction Center El Niño/Southern Oscillation (ENSO) diagnostics discussion for October 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

Malaysian palm oil cost $1,120 per ton in October 2026, up 14.3% from $980 in December 2025.

Sahidi ·10:12

How to verify: Check World Bank Pink Sheet commodity price data for palm oil for October 2026 and December 2025. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

Crude oil prices reached $125 a barrel in October 2026, nearly doubling from December 2025.

Sahidi ·11:13

How to verify: Check World Bank Pink Sheet commodity price data for crude oil for October 2026 and December 2025. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify India's September 2026 retail food inflation rate against the Reserve Bank of India's official inflation data release.
  • Check the June-September 2026 monsoon rainfall data against the India Meteorological Department (IMD) reports.
  • Confirm the current El Niño probability forecast from the US National Oceanic and Atmospheric Administration (NOAA) or similar meteorological agencies.
  • Review the latest quarterly financial results for Sun Pharma, Torrent Pharma, and Zydus Lifesciences to assess profit margins and acquisition impacts.
  • Verify the Union Cabinet's approval of the 62,370 crore rupee fertilizer subsidy through official government press releases.
  • Check Adani Group's recent SEC filings or exchange disclosures for details on the $1.45 billion equity investment for Evo Terminals.
  • Monitor global crude oil and natural gas price trends to assess ongoing pressure on fertilizer production costs.
Full transcriptexpand
0:04
Sahidi: India's food inflation jumped to 7.7% in September. But this wasn't just a sudden spike in onion prices. For months, grocery prices had been climbing in ways that annual inflation numbers barely captured. Now, with the monsoon rains, expensive imports, and rising fertilizer costs could make food inflation even
0:23
Sahidi: harder to bring down. That's our first story. And in our second story, India's pharma market had its strongest quarter in over a year. Yet, even companies like Sun Pharma, Torrent, and Zydis sold more medicines, their profits told very different stories. What's making it so difficult to turn stronger sales into
0:43
Sahidi: stronger earnings? Welcome back to the daily brief by Zeroda, Zaroda, where we cut through the noise to help you understand what's actually happening. in the most important stories from business and markets. I'm your host Sahidi and today is 13th November. Coming to the first story. In September 2026, India's retail food inflation
1:03
Sahidi: jumped to 7.7% up from 6% in August. In rural India, overall inflation crossed 6% for the first time this financial year. Now, India hasn't breached the RBIs of official inflation band of 2% to 6%. That's because the band applies to national combined inflation, which stood at 5.5%
1:23
Sahidi: in September. But the pressure on food prices is becoming harder to ignore. And this isn't just about onions or tomatoes suddenly getting expensive. Although onions did lead the search this time. These are deeper problems affecting food prices across the board. And unfortunately, these problems move slowly and unpredictably,
1:42
Sahidi: which makes them difficult to fix quickly. But before we get to those problems, there's something interesting about inflation numbers themselves. If you looked at the headline inflation figure in August, you might have wondered why it had barely moved, even though your groceries seem to be getting more expensive. The answer lies in how inflation is calculated.
2:03
Sahidi: See the headline inflation figures compares prices in a particular month with prices in the same month a year earlier. That's useful because it helps smooth out normal seasonal changes. But there is a catch. If prices were unusually high or low in the previous year, the inflation rate can give you a misleading picture. Just think about your
2:22
Sahidi: electricity bill. Imagine your bill keeps climbing through the summer. But last August you had three air conditioners running day and night, so your bill was unusually high. Now, when you compare this August bill with last August bill, it might look almost unchanged. But that doesn't mean your electricity bill hasn't been rising over the past few months.
2:43
Sahidi: And that's essentially what happened to India's vegetable prices. According to Moss Peace Pey's retail price index for vegetables, tubers, and pulses. prices rose every single month between April and August 2026. Over those four months, they climbed 19%. Households were already feeling that increase. Yet the annual inflation rate
3:02
Sahidi: for this group in August was just 1.6%.
3:06
Sahidi: Why? Because prices in August 2025 had also been unusually high. So the year-on-year year on year comparison made this year's increase look so smaller. But that changed in September. Prices in this group rose another 4.3% compared with August, taking the total increase since April to 24%.
3:27
Sahidi: In September's price level in the previous year was lower than August 2025. Those two effects combined to push annual inflation in this group from 1.6 to 9.2% in just a month. That's a huge difference in what the annual number was telling us. And onions were the biggest culprit. Retail onion
3:46
Sahidi: prices jumped nearly 36% in September alone. Wholesale onion prices, meanwhile, have nearly tripled. They were still 8.6% cheaper than a year earlier, but between April and September, tomatoes prices had actually risen 42%. So, depending on which period you compare, you could get a very different
4:06
Sahidi: impression on what was actually happening.
4:09
Unidentified speaker (UNKNOWN): Now,
4:09
Sahidi: these price indices cannot tell us exactly how much each vegetable contributed to the overall increase. But they do show that since spring, prices have largely been moving in the same direction. Up. But this isn't only an onion or tomato problem. Prices are rising. across several everyday food items at
4:29
Sahidi: the same time. Let's take grains. Overall grain inflation was a relatively mild 3.9% in September. But open market rice prices were more than 8% higher than a year earlier. And in rural areas, Joar and small millets became expensive even faster. So why did the overall grain inflation
4:49
Sahidi: number look relatively low? There were two reasons. First, wheat prices rose by less than 2%. And second, under MOSP's revised CPI rules, free welfare grain is excluded from the index. Paid ration shop grain is tracked separately and its prices barely moved. That helped keep the overall grain
5:09
Sahidi: inflation average averaged low, even while some individual grains became considerably more expensive. And the same pattern appears elsewhere. Urat and two dal prices rose more than 8%, refined cooking oil became 15% more expensive, and retail sugar prices jumped nearly 30%. Now, these increases don't stop at the
5:29
Sahidi: grocery store. Think about a tea stall or a small canteen. Milk, sugar, cooking oil, and commercial fuel are all inputs they use every day. When all of them become more expensive together, the vendor either absorbs the higher costs or raises menu prices. And that's already showing up. By September, a prepared cup
5:49
Sahidi: of tea or coffee cost about 10% more than a year earlier. Surf food in cities was up 8.7%.
5:56
Sahidi: This matters because eating outside the home has become a much bigger part of household spending. Urban households now spend 11.1% of their total budgets on beverages, snacks, and cooked meals. That's almost three times what they spend directly on grains. And people aren't particularly optimistic about prices coming down soon. In
6:16
Sahidi: the RBI's September survey of urban households, nearly 85% expected food prices to rise over the next three months. More than 3 in 5 expected food inflation to accelerate. So households aren't just noticing higher prices today, many also expect the pressure to continue. Which brings us to the
6:36
Sahidi: bigger question: why are so many food prices rising together? A major part of the answer lies in this year's summer monsoon. According to the India Meteorological Department, the country ended the June to September monsoon season with rainfall 13.5%. 13% below its 50-year average. And more than two-fifths of India received
6:56
Sahidi: less rain than normal. But the national average hides something important. Central and northeast India finished the season with rainfall close to normal. East and northeast India, however, received just 74% of normal rainfall. That was the region's lowest monsoon total since 1901. The South Peninsula
7:16
Sahidi: was in much better. It received only 76% of normal rainfall. And when rains are this unevent, the effect shows up directly in agriculture. Farmers planted less summer rice. By September, the areas sown with the Carif paddies stood at 42.
7:32
Sahidi: Compared with 43.8 million hectares a year earlier. Meanwhile, retail food inflation had already crossed 10% in Tamil Nadu and Andhra Pradesh. Some states have also started invoking formal drought rules. Maharashtra declared initial tariff drought across 265 Talukas, which are administrative divisions smaller
7:52
Sahidi: than districts. Andhra Pradesh declared drought across 388 Mundals after receiving less than half its expected rainfall between June and August. But the troubled trouble doesn't end with summer crop. A weak summer monsoon also puts the winter crop at risk. That's because winter crops like wheat, gram, and mustard depend heavily on
8:12
Sahidi: water stored in reservoirs. And when the summer rains fail, the reservoirs have less water available for winter irrigation. By November 5th, Central Water Commission data showed that India's major reservoirs were holding 121.9%. billion cubic meters of water. That's about 66% of their capacity.
8:32
Sahidi: Reservoir storage had fallen for 5 consecutive weeks after October 1st, and water levels were 27% lower than a year earlier. So the problem isn't just that India received less rain during the summer. It's that the shortage could affect what farmers are able to grow during the winter as well. Now, when India's harvest
8:52
Sahidi: falls short, the government has another. It can reduce import duties on food items like cooking oil or pulses, making it easier to bring in supplies from other countries. But this time, imports might not provide much relief. And the reason is El Nino. As we have covered before, El Nino can affect rainfall across several
9:12
Sahidi: countries at the same time. And there's a strong historical reason connection between El Nino and India's weak monsoons. According to official data from India and the US, 7 of India's 10 deficient summer monsoons between 1965 and 2025 happened during El Nino years. That doesn't mean El Nino caused every part of
9:32
Sahidi: this year's rainfall shortage, but it is already making its presence felt. And the effects may continue into winter. In early October, official US estimates put the probability of a strong or very strong Lino continuing between January and March 2027 at more than 83%. There are also signs that
9:52
Sahidi: coming winter could also be warmer than usual. In September itself, India was 0.6 degrees Celsius warmer than its average temperature between 1991 and 2020. Now, the problem with strong El Nino is that it can affect agricultural production across several tropical regions at once. So even when India wants to import
10:12
Sahidi: food, the countries supplying it might be facing their own shortages. And international prices are already showing some pressure. According to the World's Bank October data, Malaysian palm oil costs cost $1,120 per ton. That's up 14.3% from $980 in December 2025. Thai
10:32
Sahidi: broken rice reached $489 per ton, an increase of more than 28% since March. But there's another important qualification here. Not every food price increase in India can be blamed on global markets. Let's take coffee. Global Arabica and Robusta coffee beans were actually cheaper in October. than they had
10:51
Sahidi: been in January.
10:53
Unidentified speaker (UNKNOWN): So,
10:53
Sahidi: international coffee bean prices don't explain why a cup of coffee in India costs more now. But for products where India depends heavily on imports, especially cooking oil, expensive overseas supplies are already a problem. And there's another international shock making agriculture more expensive. El Nino isn't the only external problem
11:13
Sahidi: affecting India's. food prices. The conflict in West Asia has also pushed up energy costs between December 2025 and October 2026 when crude oil prices nearly doubled, reaching $125 a barrel in World Bank data. European natural gas prices tripled over the same period. Now, what does
11:33
Sahidi: expensive oil and gas have to do with the food on your plate? A lot actually. Oil and natural gas are essential inputs in modal fertilizer production. Natural gas is the main raw material used to produce ammonia, which is an important component of urea fertilizer. Another fertilizer, DAP, depends on sulfur.
11:53
Sahidi: And sulfur is extracted by oil refineries and natural gas processing plants. There's also a supply chain problem here. Nearly half of the world's traded sulfur. normally passes through the Strait of Hormuz. So when energy supplies and shipping routes are disrupted, fertilizers markets can feel the effects too. Interestingly, the prices of urea
12:13
Sahidi: and DAB have moved very differently this year. Global urea prices surged to nearly $857 per ton in April. But by October, they had fallen back to $420 per ton. DAB DEP went in the opposite direction. Its global price rose nearly 30% between January and October, reaching
12:33
Sahidi: $803 per ton. Its global price rose nearly 30% between January and October, reaching $803 per ton. Now Indian farmers don't experience these international price changes in exactly the same way. That's because the government subsidies URIA Urea and DAP through different systems. For Urea, the government fixes a
12:53
Sahidi: statutory retail base price. That keeps a standard bag near 266 while the central budget absorbs much of the impact of international price swings. As a result, wholesale Urea prices in India have remained relatively stable recently. But DAP works differently. It doesn't have a fixed retail price cap. Instead, under the
13:13
Sahidi: new nutrient-based 10B subsidy scheme, the government sets subsidies for different nutrients each season, helping keep DAP prices near 1,350 per bag. And on November 11, the Union Cabinet approved 62,370 crore rupees in winter fertilizer subsidies. That's 64% higher than last
13:33
Sahidi: winter. But there's another issue. DAP TAP imports are already slowing down. Between April and June July 2026, India imported about 18% less TAP than it did during the same period in 2025. So even if the government increases subsidies, access to fertilizer could still become an issue. And that matters
13:52
Sahidi: because the winter crop will depend on both available water and available fertilizer. So is India going to face persistently high food inflation? Not necessarily. There are still reasons prices could cool down. For instance, fresh winter vegetables usually bring down the prices of perishable foods by December. But that depends on
14:12
Sahidi: successful rabbi crop. And as we have seen, the conditions for that crop are more fragile this year. The government has also increased winter fertilizer subsidies. And if necessary, it can release food stocks to ease shortages. But this is too serious to dismiss as just another temporary increase in onion or tomato prices.
14:32
Sahidi: Over the next three months, there are three things worth watching. First, winter crop sewing. The Med department's post-monsoon outlook had focused below normal rainfall across India in October. At the same time, it expected normal northeast monsoon rainfall in southern India between October and December. So the weekly results. reservoir reports and November
14:52
Sahidi: sowing data for wheat, gram, and mustard oil will be important. They'll help show whether farmers have enough water and DB to compensate for weak summer harvest. The second thing to watch is whether higher wholesale prices continue passing through to neighborhood shops. In September, wholesale inflation for food grains, pulses, and cooking oils was running
15:12
Sahidi: ahead of retail inflation. But wholesale in retail indices measure different baskets of products with different weights. So it makes sense to track them alongside the government's daily retail price data. And finally, we should watch whether expensive food starts affecting wages and prices elsewhere in the economy. If food prices
15:32
Sahidi: remain high, rural wages could face pressure, and that could eventually contribute to broader inflation outside food and fuel. The RBI expects that measure of inflation to average 4.4% this financial year.
15:45
Unidentified speaker (UNKNOWN): With
15:45
Sahidi: the repo rate currently at 5.5%, the RBI may have little room to cut interest rates until water availability improves and everyday food prices begin settling down. So the bigger question isn't simply whether onions become cheaper next month. It's whether India's farms, reservoirs, and supply chains can recover quickly enough to
16:05
Sahidi: bring food inflation under control.
16:11
Sahidi: Coming to the second story, India's pharmaceutical market just had its strongest stretch in six quarters. According to FarmRack, medicine sales grew 12% between July and September. Higher prices accounted for much of that growth, but companies were also selling more medicines. And the country's largest drug makers performed even
16:31
Sahidi: better in India. Sun Pharma's Indian business grew 17%. CIDAS life sciences grew 19%. And Torrin Pharma's existing Indian business grew 20%. But their overall financial drips tell three very different stories. Sun Pharma's operating profit grew, but one-time charges pulled down. its
16:51
Sahidi: net profit. Torrent's operating profit jumped 54%, yet its net profit fell 10%, largely because of costs linked to its acquisition of JB Pharma. And Zydis' overall revenue grew 29%, but even its operating profit declined. So these companies are selling more medicines, but they are keeping very different amounts
17:11
Sahidi: of money. And the reason lies largely outside India. After all, India accounts for only about a third of Sun Pharma sales and around a quarter of CIDIS. Each of these companies is spending money to prepare for its next phase of growth. But each one is paying a different bill. Torrent is paying for a company it has already
17:30
Sahidi: acquired. Cidus is preparing to launch a drug that hasn't been approved, and Sun is paying for a deal that hasn't even closed. Let's start with Torrent. Torrent bought JB Pharma, and that acquisition explains much of its 50% revenue growth in this quarter. But Torrent's existing business was also doing well, growing
17:50
Sahidi: 18%. The problem was that JB Pharma itself barely grew. Torrent was integrating JB Pharma's Farmers' brands into its own sale teams and in reorganizing operations. That disrupted sales. particularly deliveries to overseas markets. The upside is that Torrin now expects to achieve its planned annual savings of
18:10
Sahidi: 450 crore within two years rather than three. But the bigger financial burden appears below operating profit. Torrin borrowed heavily to finance the acquisition. As a result, its quarterly interest bill jumped from 48 crore to 300 crore.
18:27
Sahidi: It also has to record amortization expenses for the brands it acquired from JB Farmer, reducing their accounting value over time.
18:35
Unidentified speaker (UNKNOWN): And
18:35
Sahidi: that's how Torrin could report a 54% increase in operating profit, but still see a net profit fall 10%.
18:43
Unidentified speaker (UNKNOWN): Now
18:43
Sahidi: Zydus is facing a completely different problem. It's preparing to launch Cyroglyzar, Sarroglizar, a treatment for a rare liver disease in the U.S. United States. But that launch is still awaiting approval. And preparing for it has already cost Zyders about 1.5% points of operating margin this quarter. The spending
19:03
Sahidi: is only the beginning. Zyders expects to spend around 100 million dollars or about 940 40 crore rupees every year on selling the drug, but meaningful revenue may not arrive until financial. year 2029 or even 2030. That explains some of the pressure on its profitability. But it isn't the main reason
19:22
Sahidi: ZIDE's operating margin fell from about 33% to 24%. A bigger reason is that some of its older, unusually profitable US medicines are facing more competition. At the same time, its fast-growing consumer wellness business earns thinner margins than. the prescription medicines. And this happened despite North
19:42
Sahidi: American sales growing 21%. That growth was helped by Rolvidon, a medicine used to protect cancer patients from infections, which CIDES gained through its acquisition of SRTO. Now, Sun Pharma has another challenge. Sun is preparing for an acquisition that isn't closed yet. And it is a lot riding on the deal
20:02
Sahidi: because it needs new sources of growth. Its US sales have declined for two consecutive quotos, largely because of one formerly lucrative medicine, which we will come to shortly. Even Sun's own patented medicines, its specialty drug business, have slowed. One example is Illuminate, its treatment for psoriasis, which has
20:22
Sahidi: struggled in the US. Sun's US business head blamed part of that weakness on market. conditions. But he also acknowledged problems with the company's own sales execution. And that brings us to Sun's next big bet. It's acquiring Organon in a deal worth $11.75 billion, including debt. Sun
20:42
Sahidi: expects the combined business to generate nearly twice its current habitat. editor. But the acquisition is expected to close only early next year. Until then. Sun is carrying the expenses without getting the benefit of the new business. Deal-related costs in an unrelated US legal settlement pulled its reported profit down to around
21:00
Sahidi: 1990 crore.
21:03
Sahidi: On an underlying basis, profit was around 3160 crore. And CFO warned that more such charges could appear before the deal closes. And there's also a change coming. to Sun's balance sheet. Today Sun has more cash than debt. But once it completes the Ortonon acquisition, it expects to become a net
21:23
Sahidi: borrower. So each company is making a different investment for future growth. But acquisitions and new drug launches aren't the only things putting pressure on pharma profits. There's also a bigger change in how much money companies can earn from individual medicines. Here's another important thing about pharmaceutical business. A medicine's
21:42
Sahidi: profitability doesn't depend only on how many people want to buy it. It also depends on how many companies are allowed to sell it. And two medicines, linalidomide and semaglutide, show both sides of that equation. Let's start with linalidomide. It's a blood cancer drug. It was one of the reasons Sunpharma earned unusually high profits in the U.S.
22:03
Sahidi: Under settlements with the original drug maker, generic manufacturers could only sell limited quantities of linaledomide in America between 2022 and January 2026. And that restricted the competition. And with fewer generic alternatives available, prices remained unusually high. But once those limits ended, the extra
22:23
Sahidi: profits began disappearing. That's one of the main reasons. Sun's US sales have been declining. In fact, Sun's CFO said that if you exclude those unusually high profits from linalidomide, the company's operating profit actually grew faster than its sales. So the underlying business looked better than headlines numbers suggested. Now semaglutide
22:43
Sahidi: presents almost the opposite situation. Semaglutide is the molecule behind Ozimbek. And when it came off patent in India. in March, Torrent expected it to become a major opportunity. Torrent even called it the biggest drug launch the company had ever seen. But unlike linalidomite, semaglutide faced heavy competition
23:03
Sahidi: almost immediately. By the end of March 2026, brands from 13 companies were already on sale. And by September, Gendrix accounted for about 75% of semaglutide. semaglutide's monthly volumes. So even though demand was substantial, all those manufacturers had to share the market. Torrent expects India's
23:23
Sahidi: entire Gendrix sema glutide market to be worth only around 800 crore rupees in its first year, and that amount is spread across all the companies competing in it. Even being an early leader hasn't guaranteed strong profits. In May, Torrent Torrin said semaglutide was generally. generating much lower margins than its other medicines. The main
23:42
Sahidi: ingredient was expensive and launching the product required significant marketing spending.
23:47
Unidentified speaker (UNKNOWN): So,
23:47
Sahidi: Torrin initially prioritized market share, hoping profitability would improve later. But then it ran into a supply problem.
23:56
Unidentified speaker (UNKNOWN): An
23:56
Sahidi: issue with one of its suppliers kept some of its sema glutide injections off pharmacy shells for nearly two months. As a result, torrent's share of generic semaglutide sales fell from 36% in the June quarter to 32%. It also dropped its earlier sales target of 250 crore rupees for the year. Meanwhile, Sun Pharma and
24:16
Sahidi: Ziders have been approaching the market differently. Sun overtook torrent in pre-filled semaglutide Glutide pens by July, helped partly by Torrent's torrent supply problems. Ziders, Zyders, meanwhile, manifested manufactures semaglutides for rival companies, including Lupin and Torrent. So Zyders can earn money from manufacturing the drug even when customers buy another
24:35
Sahidi: company's brand. Neither Sun nor Zyders has disclosed how much money semaglutide is bringing in. But the bigger lesson here goes beyond semaglutide. Once many manufacturers are allowed to sell the same medicine, competition can quickly turn into a price war. And in the US, generic drug makers face another problem. According to Torrent's
24:55
Sahidi: management, just three or four buyers control around 90% of the US market. That gives the buyers enormous bargaining power. So even when a company has an advantage with a particular generic drug, that advantage may not last very long. Cidus illustrates this. Despite reporting a strong quarter. in
25:15
Sahidi: North America, it expects only single-digit growth in the region this year. Partly because last year's sales were unusually high. That's why companies are increasingly moving towards medicines that are harder to copy. Of the roughly 30 products CIDIS files for approval each year, only about 10 to 12 are now simple
25:34
Sahidi: generics it's also moving into biosimilars. For instance, CIDIS holds the right to sell a biosimilar version of the cancer medicine Key Truda in the US and Canada. That product is currently under FDA review. But any eventual launch also depends on the outcome of patent litigation. So, pharmaceutical companies are trying to find medicines where
25:54
Sahidi: competition is more limited and profits can last longer. But competitors aren't the only ones deciding how much a medicine can earn. Governments are increasingly getting involved too. In October, India capped trade deal margins at 30% of the retail price for 137 cancer medicines. Now, a trade margin is the
26:14
Sahidi: difference between what a drug manufacturer charges distributors and what the patient ultimately pays. And the price reductions look dramatic. Take Brickstar, a cancer biosimilar sold by Zyders. Its retail price dropped from 25,995 per while to 3,318. That's an
26:34
Sahidi: enormous difference. But here's the important distinction:
26:38
Unidentified speaker (UNKNOWN): the
26:38
Sahidi: fall in the retail price doesn't necessarily mean the drug maker loses the entire amount. The new prices were calculated using what manufacturers were charging distributors in March 2026. So a lot. large part of the reduction falls on distributors and hospitals. And that's significant because a government committee had previously found
26:58
Sahidi: markups ranging from 170 to 700%. Hospitals have traditionally had an incentive to prefer medicines that gave them a larger margin. But with those margins now capped, brands may now have to compete more on price and doctors' preferences. And that matters, particularly. for companies like Zydos, which sells several cancer
27:18
Sahidi: biosimilars, and Sunpharma which sells cancer generics torrent has relatively less exposure because a large part of its India business comes from medicines for heart disease and diabetes. But the bigger concern is what happens next. Government officials have said these margin caps could eventually be extended beyond cancer medicines.
27:37
Sahidi: In And the Supreme Court, has also asked why they shouldn't. That could bring regulation into the very parts of the Indian pharmaceutical market that are currently growing fastest. Now, the United States is taking a different approach. Since September 29th, the US has imposed a 100% tariff on certain imported patented
27:57
Sahidi: medicines. Generic Gender medicines are exempt, as are some Indian speciality specialty medicines.
28:03
Sahidi: The US has also proposed tariffs on imported gender starting in 2028. Those proposed tariffs aren't in force yet, but if implemented, they could have substantial impact on ZIDUS, which earns more than two-fifths of its revenue from North America. San Pharma faces a different kind of exposure. A growing share of
28:23
Sahidi: its US business comes from its own patented medicines, which fall under the current tariff rules. So, Sun, along with around 25 other drug makers, has reached an agreement with Washington. Under that agreement, Sun will offer state Medicaid program medicine prices similar to those in other wealthy countries. In return, it will receive more than two
28:43
Sahidi: years of relief from tariffs on its patented medicines. It will also be exempt from two proposed Medicaid pricing rules that could. otherwise have affected clinical administrative medicines such as aluminum. So governments on both sides are trying to influence medicine prices but in very different ways. And these policy changes could have
29:03
Sahidi: an important effect on the company's future profitability. Which brings us back to the original question. These pharmaceutical companies are selling more medicines, but will the money they're spending today actually? generate better profits tomorrow? For Torin, that means getting JB Pharma back to double digit growth. For Sun, it means recovering sales of
29:23
Sahidi: Illumina while successfully completing its Orkinan acquisition. And for Zydos, it means launching Sarroglitzer without putting more pressure on its operating margins. Their Indian businesses are already growing strongly. The question now is whether their investment investments and challenges outside India will allow the growth to translate
29:43
Sahidi: into stronger overall profits.
29:49
Sahidi: And now a few quick tidbits. Number one, the Union Cabinet has approved a fertilizer subsidy budget of 62,370 crore rupees for the Rabbi 2026-2027 season. The allocation covers phosphatic and potassium fertilizers under the nutrient-based subsidy scheme
30:09
Sahidi: for the 6 months ending March 2027. It's about 24,480 crore higher than previous year's budget and is meant to protect farmers from fluctuations in global fertilizer prices. Number 2. The RBI has issued updated rules for domestic money transfers for. while keeping the existing 50,000
30:29
Sahidi: rupee limit for cash-based NEFT transfers by walk-in customers. The new framework also strengthens fraud prevention requirements for banks and non-bank entities. These include checks on how frequently transactions occur, alerts when customers receive money, and separate identifiers for cash-based transfers. Number three,
30:49
Sahidi: the Adani group is expected. to invest up to $1.45 billion in equity to help finance its proposed acquisition of European liquid storage company Evo's Terminals. The overall acquisition is valued at $2.9 billion. As part of the financing arrangement, the group is also reportedly
31:09
Sahidi: working with global lenders to refinance approximately 1.3 billion euros of Evo's existing debt. Number 4. Pajaj Finance is preparing to raise up to 11,700 crore rupees or about 1.2 billion dollars from institutional investors. The fundraising would happen through a
31:28
Sahidi: qualified institutions placement or QIP. The company has also completed investor roadshows roads and could launch the share sale soon, although the final amount entire and timing may still change. Number 5. Foreign airlines are opposing Adani's airport's proposal to reduce capacity at Mumbai Airport and shift some of
31:48
Sahidi: international flights to Navi Mumbai from summer 2027. The airport operator says reduction is needed during the redevelopment of Terminal 1. But airlines argue that removing their long-held long held flight slots could disrupt their networks and affect passenger connections. That's all the news I have for you. Thank you so much for watching
32:08
Sahidi: and see you in the next one.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.

More from The Daily Brief

The Daily Brief

Coal India’s largest subsidiary goes public

Episode discussion: Coal India subsidiary MCL IPO details, regulatory risks, and Indian wire market dynamics discussed

Speakers’ claims: Speakers analyze the upcoming IPO of Mahanadi Coalfields Limited (MCL), noting it is an offer-for-sale transaction where proceeds go to parent Coal India rather than MCL itself. They highlight MCL's operational efficiency and low costs but warn of lower coal quality and significant regulatory risks, including a potential 31,000 crore rupee tax liability in Odisha. The discussion also covers the Indian wire market, where new entrants like Ultratech Cement are challenging incumbents like Polycab and Havells. Incumbents are responding by shifting focus to high-voltage cables and exports to mitigate competition in the wire segment.

IPOCoal IndiaMahanadi Coalfields
27 min0 assets10 claims to verify
The Daily Brief

The world sees a boom in Chinese yuan bonds

Episode discussion: Western entities issue record yuan bonds amid rate differentials; India aviation rules clarified

Speakers’ claims: Speakers note a surge in yuan bond issuance by Western banks and governments, driven by lower Chinese interest rates and geopolitical diversification, though the dollar's reserve dominance and yuan capital controls remain significant constraints. The episode also covers India's new aviation regulations, which preserve airline pricing freedom while enhancing transparency and clarifying emergency intervention powers, attributing high fares to operational costs and reduced capacity rather than price gouging. Brief updates touch on Blackstone's investment in IAFL Finance, Patna Municipal Corporation's bond listing, government rice stock reporting rules, TSMC's AI firm investments, and an extension of the medical devices PLI scheme.

Chinese Yuan BondsGlobal ReservesIndia Aviation
25 min1 assets10 claims to verify
All insights